Pharmacogenomics

Cancer treatment is entering a transformative era—where therapies are not only targeted to the type of cancer but also personalized to the genetic makeup of each patient. This precision medicine approach is driven by onco-pharmacogenomics, which uses genetic testing to predict how patients will respond to specific cancer drugs. Dromic Labs is at the forefront […]

In the rapidly evolving field of oncology, oncogenetic testing has become pivotal in advancing personalized cancer therapy. By harnessing the power of genetic insights, this approach tailors treatments to the individual’s unique genetic profile, optimizing efficacy and minimizing adverse effects. This blog delves into how oncogenetic testing is revolutionizing cancer treatment and highlights some of

Cancer, a formidable adversary that has long challenged the medical community, is a disease characterized by its remarkable complexity and heterogeneity. For decades, the traditional one-size-fits-all approach to cancer treatment has often fallen short, leaving many patients without effective options and grappling with the debilitating side effects of conventional therapies. However, a transformative shift is